Taking The Temperature Of Accelerated Approval: An Interview With Ariad's President Of R&D Tim Clackson (Part 1 Of 2)
R&D head talks about the company's lead candidate ponatinib's developmental plan under accelerated approval.
R&D head talks about the company's lead candidate ponatinib's developmental plan under accelerated approval.